Jeremie Calais
@CalaisJeremie
Followers
2K
Following
2K
Statuses
639
Nuclear medicine and theranostics at UCLA @UCLA @UCLAJCCC @UCLATheranostic @UCLAnewsroom @UCLAHealth #PETCT #nuclearmedicine #theranostics
Los Angeles, CA
Joined October 2020
RT @PSMAconference: TWO WEEKS to submit abstracts for presentation at the 2025 PSMA and Beyond Conference! The deadline has been extended t…
0
6
0
RT @DrMHofman: SPECT deserves RESPECT! @drlouiseemmett makes the argument that it is a powerful tool for theranostics ➤ enabling early,…
0
26
0
RT @PSMAconference: Start the new year right by joining us at the 2025 PSMA and Beyond Conference this March in LA! The program includes a…
0
9
0
Low- and High-Volume Disease in mHSPC: from CHAARTED to #PSMA PET #stagemigration
@UnterrainerLena @JournalofNucMed @thomashopemd @UCLAHealth @SathegkeM @AmarUKishan @CzerninJohannes @ProfKHerrmann @Wes_Armstrong_
2
26
91
RT @UCLAHealthJCCC: A new study in @JAMANetworkOpen and led by @CalaisJeremie has found that many cases of high-risk nonmetastatic hormone-…
0
6
0
Stage Migration by PSMA PET in EMBARK-like patients (high risk BCR prostate cancer) @JAMANetworkOpen @UCLAHealth @AmarUKishan @RobertReiterMD @CzerninJohannes
A new study in @JAMANetworkOpen and led by @CalaisJeremie has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought. Read more about the findings:
1
9
40
RT @thomashopemd: We are excited to host the second PSMA PET conference with @UCLATheranostic and the @PCF_Science in March. The abstract d…
0
10
0
RT @JournalofNucMed: New SNMMI procedure standard/EANM practice guideline for fibroblast activation protein PET: #…
0
12
0
RT @AlanBryce9: Very happy to share the manuscript from the 2024 United States Prostate Cancer Consensus Conference. Our goal with this is…
0
28
0
RT @neerajaiims: Just in @JournalCancer 👉Consensus statement from 2024 United States #ProstateCancer Conference (USPCC)👉Management of PSA r…
0
75
0
RT @DrMHofman: Longer follow-up from our landmark ProPSMA study just out @EurUrolOncol: PSMA nodal status is prognostic! At 3 years 70% of…
0
49
0
SNMMI/EANM Procedure Standard Guidelines for FAP PET, first version now online. Likely to evolve in a few years, but good to have a 1.0. @SNM_MI @EANM_NucMed @JournalofNucMed
@thomashopemd @ZanElcin @ProfKHerrmann
0
14
41
RT @PSMAconference: Accepting abstracts for presentation at the 2025 PSMA & Beyond Conference! Be sure to submit by Jan 10! More info at: h…
0
5
0
RT @DrAIravani: Moving toward precision response assessment and dynamic risk startification by SPECT/CT in mCRPC receiving LuPSMA! #PSMA #T…
0
14
0
After PSMAfore and SPLASH, The ECLIPSE trial also met its primary endpoint Hopefully we will get LuPSMA therapy approved for chemotherapy-naive mCRPC patients one day. #PSMA #theranostics #prostatecancer @Curium_Pharma
1
23
60
RT @PSMAconference: Registration is open for the 2025 PSMA & Beyond Conference! Join us in LA on March 28-29! Register now at: https://t.co…
0
4
0
RT @urotoday: Therapy resistance and combination therapies. Presentation by @CzerninJohannes exploring the challenges of resistance in PSMA…
0
3
0
RT @JournalofNucMed: New in JNM: The best patient care practices for administering PSMA-targeted radiopharmaceutical therapy. https://t.co/…
0
12
0